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Background. Forthright reporting of financial ties and conflicts of interest of researchers is associated with public trust in and
esteem for the scientific enterprise. Methods/Principal Findings. We searched Lexis/Nexis Academic News for the top news
stories in science published in 2004 and 2005. We conducted a content analysis of 1152 newspaper stories. Funders of the
research were identified in 38% of stories, financial ties of the researchers were reported in 11% of stories, and 5% reported
financial ties of sources quoted. Of 73 stories not reporting on financial ties, 27% had financial ties publicly disclosed in
scholarly journals. Conclusions/Significance. Because science journalists often did not report conflict of interest information,
adherence to gold-standard recommendations for science journalism was low. Journalists work under many different
constraints, but nonetheless news reports of scientific research were incomplete, potentially eroding public trust in science.
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INTRODUCTION
Despite the rise of electronic media, the print news media continue
to provide an important source of science news to the lay public
[1,2]. In fact, because the news media influence public opinion,
the press is often used strategically by researchers seeking attention
and funding [3], and by advocates seeking policy change [4]. The
lay press is also an important source of information on new
research for the scientific community [5].
When scientific research is reported in the lay press, important
information regarding context and methods is often lost [6]. A
study of science news in three leading papers found the omission of
research methods to be a steady problem over three decades [7].
Science journalism also often fails to describe the limitations of the
study, funding sources supporting the research, or financial
conflicts of interests of investigators [2,8,9].
Reporting funding sources, financial ties of investigators, and
study limitations are important because of potential conflicts of
interest. Many scholars agree that the type of conflict of interest
most likely to affect the public’s trust is a financial conflict where the
scientist might gain financially as a result of a particular research
outcome [10,11,12]. Financial ties of investigators with their
sponsors (e.g.stockownershipand consultingincome)areassociated
with the reporting of favorable research results and conclusions for
the sponsor [13,14,15,16]. Moreover, financial ties between
researchers and their corporate sponsors are increasing in
prevalence and magnitude [17,18]. Biased research can be
intentional or unintentional [19], and can result from damaged
objectivity at multiple stages in the research process, including
conceptualization of the question, design of the research, conduct of
the research, or publication (or not) of the research [20]. For these
reasons, many scientific journals are now requiring that authors
disclose financial ties and potential conflicts of interest [21,22,23].
Previous studies of health care journalism do not fully examine
the reporting of conflicts of interest, instead focusing on the
accuracy of the data being reported. One study of lay press reports
assessed 60 health care stories and developed an instrument for
scoring the quality of reporting, considering whether the report
contains errors of omission in descriptions of the research and
methods, or is otherwise misleading about the credibility of sources
[24]. Similarly, a review of health news identified ‘‘bias and
conflicts of interest’’ as a problem area in reporting, and suggested
that readers be told explicitly if researchers and funders could
financially benefit from the results [25]. A study of 207 news stories
on new drug therapies found that 85 percent cited experts with
financial ties to the drug manufacturer, but that only about one-
third of these reported the relationship [26]. The few studies to
date suggest that there is little reporting on financial conflicts of
interest in clinical research.
In addition, few studies have examined how new developments
in basic science are reported in the media, with some attention to
financial ties. A study of 228 media stories on genetics found that
13% of stories mentioned funding sources for the research and 3%
mentioned how the investigator could financially benefit from the
discovery [27]. The same research team interviewed scientists and
science journalists and found that they mistrust each other greatly,
and that one solution would be to regularly but responsibly
disclose financial conflicts of interest [28]. Problems of conflicts of
interest in science are themselves occasionally the subjects of news
stories, usually with negative connotations that fuel a suspicion of
science among the public [29]. Forthright discussions of financial
ties and conflicts of interest among researchers and funders are
associated with public trust and public esteem of the scientific
enterprise [30,31].
Our study examines science journalism covering the most
important developments in basic science, clinical research, and
engineering from 2004 and 2005. We sought to describe how print
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how funding and financial ties of researchers were reported.
METHODS
Our objective was to determine the extent and nature of reporting
of conflicts of interest and research in clinical, engineering, and
basic science. We conducted a content analysis of 1152 newspaper
stories according to the methods described below.
Search strategy
We first identified the topics of top news stories in science from the
past five years according to year-end lists published in four
journals: Discovery, Scientific American, Popular Science, and
Science. We excluded topics not relevant to basic science, clinical
studies, and engineering, and then took the top fifteen topics for
our study. These included global warming, nanotechnology, stem
cells, gamma ray, new matter, and ten others (Table 1).
We searched Lexis/Nexis Academic News, which contains full-
text news from a source list of about 260 different United States
major and regional newspapers and wire services, for stories on
these topics from 2004 and 2005. Some of the topics were overly
broad as search terms, so they were paired with the word ‘‘study’’ or
‘‘research’’ in order to find relevant stories describing new studies.
We searched ‘‘US News’’ for each of the four regions in the
database: Midwest, Northeast, Southeast, and Westfrom January 1,
2004 to November 30, 2005 (when the searching began). This
yielded over 9800 hits on news stories. We included news stories
from any section but excluded obituaries, book reviews, editorials,
and other items not reporting science research. We then conducted
stratified sampling by randomly selecting 100 stories from each of
the 15 topics, although several topics yielded fewer than 100 hits,
and so all the stories were included (Table 1). After eliminating any
duplicates,ourfinalsampleconsisted of1152 newsstoriesonthetop
15 topics in new science and medicine research.
Data extraction for content analysis of media stories
Three different coders divided the total set of stories. Our coders
were an advanced graduate student, a postdoctoral fellow, and an
assistant professor. Working from a hard copy of the news item, we
entered the information into a qualitative data software package.
For each story we noted 20 characteristics: title, author,
newspaper, length, section of newspaper, date, topic, category
(basic, clinical, engineering), funder of research, financial tie
reported for investigators who conducted study, type of financial
tie, company with the tie, whose tie, amount of tie, sources quoted,
type of financial ties of source quoted, which source with tie,
amount of source tie, how the research was portrayed (positive
towards the new finding, neutral, critical), and how the financial
ties were portrayed. We also had extra fields for research notes and
financial tie notes. Any discrepancies were discussed and resolved
by the three coders and the principal investigator. Below we report
the descriptive statistics from this study.
Determining concordance between reporting of
financial ties in media stories and related scientific
journal articles
We determined whether the information on funding sources for
the study and financial ties of researchers was readily available to
journalists. We conducted a stratified random sample of 1020
newspaper stories that did not report any financial tie information.
Using a random number generator, we selected 112 media stories,
representing most of our 15 categories. Of these, we were able to
obtain the citation information for 73 scientific journal articles that
were reported in the 112 stories. We searched PubMed and
Google for the scientific journal articles that were mentioned in
these media stories. We then examined these journal articles for
disclosures of research funding and statements regarding financial
ties of the authors.
RESULTS
Of the 1152 news stories, 56% reported basic scientific research,
38% clinical research, and 6% engineering (Table 2). Of the 15
topics, most concerned global warming, toxic exposures, and aging
(Table 1). The average length of the stories was 761 words. The
most frequent publishers of the stories were the Associated Press,
New York Times, and Washington Post (Table 3).
Funding for the research described in the news
story
Funders of the research were identified in 438/1152 (38%) stories,
with the most frequent funders being various U.S. government
agencies (Table 4). Reported funding sources also included several
private nonprofit organizations, a few foreign governments, and
over twenty private corporations. The most frequently identified
government funder was the National Institutes of Health, followed
by the National Aeronautics and Space Administration and the
Centers for Disease Control and Prevention. The most frequently
identified non-government funders (including the corporate and
Table 1. Frequency of Stories by Topic.
......................................................................
Frequency Percent
global warming 109 9.5
toxic exposure 103 8.9
aging 101 8.8
infectious disease 98 8.5
stem cells 98 8.5
gamma ray 89 7.7
reproductive biology 89 7.7
genetics 86 7.5
genomics 86 7.5
nanotechnology 81 7.0
cloning 81 7.0
cancer therapy 75 6.5
genetically modified organisms 42 3.6
new matter 7 .6
chemistry 7 .6
Total 1152 100.0
doi:10.1371/journal.pone.0001266.t001
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Table 2. Science Category of Sampled News Stories.
......................................................................
Category Number Percent
Basic 648 56.3
Clinical 441 38.3
Engineering 63 5.5
Total 1152 100
doi:10.1371/journal.pone.0001266.t002
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and Advanced Cell Technology.
Financial ties of researchers
Financial ties were defined to include direct corporate sponsorship
of research, investigators with stock ownership, equity, patent
royalties, consulting fees, honoraria, service on boards of directors
or scientific advisory boards, and institutional ties such as the
researcher’s university having equity in a company funding the
research. Financial ties of the researchers who conducted the
studies described in the news stories were reported in 11% of
stories (132/1152). Researchers were listed with financial ties to
major private corporations like Pfizer, Proctor & Gamble,
Genentech, Merck, Monsanto, Ford, and others (Table 5). As
shown in Table 6, positive identification of ties occurred most
often in nanotechnology, cloning, and genomics. Global warming
had zero. Of the 132 stories that described financial ties, 65
reported basic science research, 49 reported clinical research, and
18 reported advances in engineering.
In 105 of the 132 media stories reporting financial ties, we were
able to identify the type of financial tie reported. We found various
types of financial ties, including research funding, institutional
connections, consulting fees, and holding patents and/or selling
related products. The type of financial tie reported most frequently
in news stories was that quoted researchers were employed by the
company that funded the study, often listed as ‘‘biotech’’ and
‘‘private lab.’’ Many of the stories disclosed that the researchers
had intellectual property that could create conflicts of interest,
such as likely commercial applications and plans to seek patents.
Fifty-six stories identified by name the researcher who had the
financial tie. In 11 of 132 stories, the dollar amounts of the
financial tie were reported, with a wide range. One tie was listed at
$24 million, two at $1 million, and two at $100,000.
Financial ties of sources quoted in stories
We examined how sources quoted in each media story were
identified and coded for financial ties of sources, if mentioned. We
were able to code the general affiliation of quoted sources in 10%
of news items, (111/1152 stories). Sources were most often
affiliated with universities (32 stories). The remaining sources
Table 4. Selected Research Funders Identified.
......................................................................
Funder Frequency Percent
None Stated 714 61.9%
NIH 49 4.3
NASA 28 2.4
CDC 19 1.6
-------
Union of Concerned Scientists 9 0.8
Pfizer 4 0.3
Advanced Cell Technology 3 0.3
Aderans 3 0.3
doi:10.1371/journal.pone.0001266.t004
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Table 3. Top sources of science news stories (those above 2%
of sample)
......................................................................
Newspaper/Source Number of Stories Percent of Total
Associated Press 158 13.7
New York Times 68 5.9
Washington Post 53 4.6
Connecticut Post 37 3.2
Boston Globe 33 2.9
Houston Chronicle 27 2.3
San Francisco Chronicle 26 2.3
Ventura County Star 25 2.2
Milwaukee Journal Sentinel 24 2.1
doi:10.1371/journal.pone.0001266.t003
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Table 5. Examples of researcher financial ties to private for-
profit corporations.
......................................................................
Pfizer (most frequently found)
Proctor & Gamble
Genentech
Merck
Monsanto
Ford
GlaxoSmithKline
Intel
Wyeth Vaccines
Quantum Dot
Novartis
DuPont
Chiron
Pratt & Whitney
Sygenta
doi:10.1371/journal.pone.0001266.t005
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Table 6. Financial ties of researchers disclosed by topic.
......................................................................
Ties Disclosed
(no. of stories)
Ties Not Disclosed
(no. of stories)
Aging 9 92
Cancer therapy 6 71
Chemistry 0 7
Cloning 23 58
Gamma ray 9 80
Genetics 9 77
Genomics 14 72
Global warming 0 109
GMO 8 34
Infectious diseases 11 87
Nanotechnology 25 56
New matter 0 7
Reproductive biology 12 77
Stem cells 2 96
Toxic exposures 4 99
Total 132 1020
doi:10.1371/journal.pone.0001266.t006
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PLoS ONE | www.plosone.org 3 December 2007 | Issue 12 | e1266reported in stories had various industry affiliations, including
specific company names such as Advanced Cell Technology,
Alliant, DuPont, Honeywell, and one source was a founder of
a company acquired by a competitor of the new research in
question. About 5% of the news stories (55/1152, or half of the
111 stories that identified sources) disclosed that the sources
quoted had financial ties to the research results, and they named
which source had the tie. The dollar amount of the tie was only
stated in one instance ($4 million).
Portrayal of research and financial ties
We found an even split between positive and neutral portrayals of
science research, and only a few critical news stories. The research
was portrayed positively in about 49% (562/1152) of the media
stories, and neutrally in about 49% (560/1152). The remaining 30
news items (2%) were critical of the research. One example of
critical portrayal of new research was the news of breakthroughs in
animal cloning from August 2005. Several stories presented the new
findings together with related ethical dilemmas, the high economic
costs, and the doubt surrounding uses of cloned animals [32].
Anotherstorypresentedthe viewsofenvironmentalistscriticalofthe
methods of new research concerned the results of state testing of
toxic vapors in the home, which [33]. An example of a positive story
is one on the new cancer drug Herceptin, which quoted patients
who think the drug ‘‘works wonders,’’ and is ‘‘miraculous’’ and
‘‘revolutionary,’’ [34]. That story did include the information that
the research was funded in part by Roche and Genentech, the
makers of Herceptin. In another example of positive portrayal of
research, stories about progress in nanotechnology often emphasize
the benefits to local economic development and the potential profits
from industry partnerships [35]. Neutral stories stated the findings
of the study, with no additional qualifying statements.
We also coded for the portrayal of financial ties, although this
was more difficult to determine. In the 132 stories that reported
a financial tie, 5 were coded as positive, one negative, and 126
were neutral or defied characterization. The story that portrayed
the financial tie negatively described research from Dupont on the
safety of its own chemical, but also reported that ‘‘critics of the
company question how the study was done and question Dupont’s
interpretation of the results,’’ [36]. Positive portrayals of financial
ties often explain that public-private partnerships can be very
profitable. One news story describes how the University of New
Mexico had joined with a company from Iceland to conduct
research in genomics, and stated that the governor and others
agreed that the arrangement ‘‘was a model for what needs to
happen in New Mexico to translate research into commercial
products and help expand the state’s economy,’’ [37]. Stories
coded as ‘‘neutral’’ portrayals presented the financial tie in-
formation without presenting its advantages or disadvantages, or
having any other evaluative language.
Concordance between financial ties disclosed in
media stories and scientific papers
We sampled from the 1020 news stories that did not report
financial ties to determine if the published academic journal article
that was covered in the story disclosed that authors or researchers
had financial ties. Of the 73 journal articles identified, 20 (27%)
reported financial ties of the authors in the published manuscript
(i.e., stock ownership, honoraria, consulting), 22 articles (30%)
specified that the authors had no competing or conflicting
interests, and 31 (43%) had no mention whatsoever of competing
interests. Thus, financial tie information was readily available in
44 scientific journal articles which were reported on in stories that
did not mention financial ties.
DISCUSSION
Reporting financial ties of researchers was limited. Because of the
importance of high-quality reporting in science, The Common-
wealth Fund publishes a ‘‘Tipsheet for Reporting on Drugs,
Devices and Medical Technologies,’’ [38]. This is arguably
a comprehensive ‘‘gold standard’’ checklist for responsible
reporting of new medical therapy, and could be applied to all
scientific findings. The Tipsheet recommends that reporters
consider seven items: the potential benefits, potential harms,
sources of information and their financial ties, strength of
evidence, historical context, possible alternatives, and costs related
to new treatments. Our study results are relevant to the third
‘‘tip,’’ that reporters should determine the links between sources of
information and those who stand to gain from promoting the new
research. We found that information about funders, financial ties,
and other conflicts of interest seldom appear in the news story,
even when the information is clearly available to the journalist.
While the Tipsheet was designed for clinical research news, we
found that the reporting of potential conflicts of interest was
similarly infrequent across the categories of research; stories about
basic science, clinical research, and engineering were all in-
complete. New developments in basic science and engineering can
have significant impacts on the public similar to clinical research
describing new therapies. Furthermore, the vast majority of
reporting on new research was favorable or neutral suggesting that
readers of the news stories would not be very critical of the
research. Yet financial tie information was reported in only about
10% of science news stories. Inclusion of financial tie information
in media stories may make readers more skeptical because
evidence suggests financial disclosures in scientific articles makes
readers more critical of the results [39]. If the sources really had no
financial ties, this should also be communicated to readers in order
to promote more informed judgment of the science research.
Certainly, journalists face various constraints and barriers while
reporting science news. For example, they may confront editorial
controls, word limits, time limits and deadlines, and most
importantly the facts about sources with financial ties may be
difficult to discover. One source of financial tie information about
researchers is from scientific journals, but a recent survey found
that just 33% of scientific journals have a clear policy on
disclosure, with engineering journals having the least disclosure
[21]. In our study, we were able to locate financial disclosures in
the cited journal articles just 27% of the time. However, even
when information on financial ties of researchers was obtainable
from the underlying scientific journal article, this information did
not make it into the media story. Furthermore, our definition of
financial ties was very broad to include research funding. Journals
from all disciplines routinely report the funding sources of research
studies. Yet funding information, including government and public
sources, was reported in less than two-fifths of stories.
Information about the financial ties of researchers is relevant and
important to the consumers of the news As more scientific journals
adopt financial disclosure standards, information about funding,
financial ties and conflicts of interest is becoming increasingly available
to the journalists who report the news. We urge science journalists to
incorporate the Commonwealth Fund recommendations and to
consider such information one important piece of the news story.
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